Don Minckler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Don Minckler has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Angele Nalbandian
From the Gavin Herbert Eye Institute, Department of Ophthalmology (D.S.M., D.J.B., A.N., D.W.S.), USA; Department of Laboratory Medicine (Ocular Pathology), University of California, Irvine, California, (D.S.M.), USA
1 shared publicationCassiana E Bittencourt
Assistant Professor, Department of Laboratory Medicine, Director of Microbiology, University of California Irvine, USA
1 shared publicationCatherine Y. Liu
Gavin Herbert Eye Institute, University of California Irvine, Irvine, Calif., USA
1 shared publication- Dale K. Heuer
Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA
1 shared publication Donald J. Brown
From the Gavin Herbert Eye Institute, Department of Ophthalmology (D.S.M., D.J.B., A.N., D.W.S.), USA; Department of Laboratory Medicine (Ocular Pathology), University of California, Irvine, California, (D.S.M.), USA
1 shared publicationDonny W. Suh
From the Gavin Herbert Eye Institute, Department of Ophthalmology (D.S.M., D.J.B., A.N., D.W.S.), USA; Department of Laboratory Medicine (Ocular Pathology), University of California, Irvine, California, (D.S.M.), USA
1 shared publication
Latest Publications
- Open Access
- 21 December 2023
- Published by Gavin Publishers in Archives of Surgery and Clinical Case Reports
- Vol. 6 (2)
Demodex Folliculorum can Cause Pyogenic Granuloma of Conjunctiva
An elderly Caucasian female with a history of oral lichen planus and functional nasolacrimal obstruction underwent bilateral Dacryocystorhinostomy (DC
- 21 December 2023
- Published by Gavin Publishers in Archives of Surgery and Clinical Case Reports
- Vol. 6 (2)
Open AccessDemodex Folliculorum can Cause Pyogenic Granuloma of Conjunctiva
An elderly Caucasian female with a history of oral lichen planus and functional nasolacrimal obstruction underwent bilateral Dacryocystorhinostomy (DC
- Open Access
- 25 September 2023
- Published by Heighten Science Publications Corporation in International Journal of Clinical and Experimental Ophthalmology
- Vol. 7 (2) , 006-007
Clinically Observable Ocular Manifestations of Axonal Transport
This report illustrates and provides a novel explanation for post-trabeculectomy improvements in the visual field, cup disc contours, and apparent deepening of an arcuate nerve fiber layer (NFL) defect after trabeculectomy for open-angle glaucoma. These changes are all plausible manifestations of recovered axonal transport and thickening retina, previously thinned by elevated intraocular pressure (IOP). Serial pre-and post-operative clinical fundus photos in case 1(A,B) demonstrate increased prominence of an inferior temporal arcuate nerve fiber layer defect, improved cup disc ratio, and visual field following eye pressure lowering by + 50% after trabeculectomy. Case 2 (C,D) also demonstrates obvious cup disc improvement in post-operative photos with associated improvement in visual field after trabeculectomy and lowering IOP by + 30%. We suggest that elevated IOP suppresses primarily orthograde axonal transport resulting in nerve fiber layer (NFL) thinning that can recover back to normal thickness when IOP is surgically lowered by the magnitude achieved in these two examples.
- 25 September 2023
- Published by Heighten Science Publications Corporation in International Journal of Clinical and Experimental Ophthalmology
- Vol. 7 (2) , 006-007
Open AccessClinically Observable Ocular Manifestations of Axonal Transport
This report illustrates and provides a novel explanation for post-trabeculectomy improvements in the visual field, cup disc contours, and apparent deepening of an arcuate nerve fiber layer (NFL) defect after trabeculectomy for open-angle glaucoma. These changes are all plausible manifestations of recovered axonal transport and thickening retina, previously thinned by elevated intraocular pressure (IOP). Serial pre-and post-operative clinical fundus photos in case 1(A,B) demonstrate increased prominence of an inferior temporal arcuate nerve fiber layer defect, improved cup disc ratio, and visual field following eye pressure lowering by + 50% after trabeculectomy. Case 2 (C,D) also demonstrates obvious cup disc improvement in post-operative photos with associated improvement in visual field after trabeculectomy and lowering IOP by + 30%. We suggest that elevated IOP suppresses primarily orthograde axonal transport resulting in nerve fiber layer (NFL) thinning that can recover back to normal thickness when IOP is surgically lowered by the magnitude achieved in these two examples.
- 19 January 2023
- Published by Elsevier in Ophthalmology
- Vol. 130 (2) , 137-138
Papilledema: An Inaccurate Term in Our Medical Vocabulary
- 19 January 2023
- Published by Elsevier in Ophthalmology
- Vol. 130 (2) , 137-138
Papilledema: An Inaccurate Term in Our Medical Vocabulary
- 2 March 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 240, 58-66
Amyloid Precursor Protein in Abusive Head Trauma Suspects
- 2 March 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 240, 58-66
Amyloid Precursor Protein in Abusive Head Trauma Suspects
- 1 September 2016
- Published by Wolters Kluwer Health in Cornea
- Vol. 35 (9) , 1257-1260
An Intractable Case of Prototheca Keratitis and Chronic Endophthalmitis in Stevens–Johnson Syndrome With Boston Type 1 Keratoprosthesis
To report a case of recalcitrant Prototheca spp. keratitis and endophthalmitis in a patient with Stevens-Johnson syndrome (SJS) and Boston type 1 keratoprosthesis (B1 KPro). Case report. A 67-year-old female with a history of SJS with chronic severe ocular surface disease in her monocular left eye underwent placement of a B1 KPro. Her course was subsequently complicated by persistent Prototheca spp. keratitis and endophthalmitis requiring ongoing treatment with triazole and polyene antifungal agents and multiple surgical revisions of her keratoprosthesis. Protothecosis is an algal infection that is rarely pathologic in humans, but when present can be difficult to manage. We present the second known case of persistent chronic Prototheca spp. keratitis and endophthalmitis in a patient with long-standing SJS and B1 KPro.
- 1 September 2016
- Published by Wolters Kluwer Health in Cornea
- Vol. 35 (9) , 1257-1260
An Intractable Case of Prototheca Keratitis and Chronic Endophthalmitis in Stevens–Johnson Syndrome With Boston Type 1 Keratoprosthesis
To report a case of recalcitrant Prototheca spp. keratitis and endophthalmitis in a patient with Stevens-Johnson syndrome (SJS) and Boston type 1 keratoprosthesis (B1 KPro). Case report. A 67-year-old female with a history of SJS with chronic severe ocular surface disease in her monocular left eye underwent placement of a B1 KPro. Her course was subsequently complicated by persistent Prototheca spp. keratitis and endophthalmitis requiring ongoing treatment with triazole and polyene antifungal agents and multiple surgical revisions of her keratoprosthesis. Protothecosis is an algal infection that is rarely pathologic in humans, but when present can be difficult to manage. We present the second known case of persistent chronic Prototheca spp. keratitis and endophthalmitis in a patient with long-standing SJS and B1 KPro.
- Open Access
- 9 February 2016
- Published by S. Karger AG in Ocular Oncology and Pathology
- Vol. 2 (3) , 185-189
Vascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation
A 34-year-old patient presented with a right orbito-facial mass since childhood, consistent with a congenital arteriovenous (AV) malformation. Prior to presentation, she had multiple incomplete surgical resections and embolizations with N-butyl acetyl acrylate and Onyx-18. The patient reported gradual, progressive vision loss shortly after Onyx-18 embolization. Five months after embolization, she presented with decreased vision, disfigurement and mechanical ptosis relating to a large subcutaneous mass affecting the medial right upper eyelid and forehead. Significant exam findings included a visual acuity of 20/400 (20/60 prior to embolization), an afferent pupillary defect, and optic disc pallor. MRI and angiography revealed a persistent AV malformation with feeders from the ophthalmic artery and an absent choroidal flush to the right eye. Pathology from surgical resection showed a significant foreign body giant cell reaction to the embolization material adjacent to the vessels. We suggest that an incomplete embolization with Onyx-18 may have caused vascular steal syndrome from the ophthalmic artery.
- 9 February 2016
- Published by S. Karger AG in Ocular Oncology and Pathology
- Vol. 2 (3) , 185-189
Open AccessVascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation
A 34-year-old patient presented with a right orbito-facial mass since childhood, consistent with a congenital arteriovenous (AV) malformation. Prior to presentation, she had multiple incomplete surgical resections and embolizations with N-butyl acetyl acrylate and Onyx-18. The patient reported gradual, progressive vision loss shortly after Onyx-18 embolization. Five months after embolization, she presented with decreased vision, disfigurement and mechanical ptosis relating to a large subcutaneous mass affecting the medial right upper eyelid and forehead. Significant exam findings included a visual acuity of 20/400 (20/60 prior to embolization), an afferent pupillary defect, and optic disc pallor. MRI and angiography revealed a persistent AV malformation with feeders from the ophthalmic artery and an absent choroidal flush to the right eye. Pathology from surgical resection showed a significant foreign body giant cell reaction to the embolization material adjacent to the vessels. We suggest that an incomplete embolization with Onyx-18 may have caused vascular steal syndrome from the ophthalmic artery.
- 1 July 1998
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 29 (7) , 552-561
Trabeculectomy With Intraoperative 5-Fluorouracil
* BACKGROUND AND OBJECTIVE: To investigate the outcome and complication rates of trabeculectomy following the combined use of intraoperative, topical 5-fluorouracil (5-FU) and low-dose, postoperative subconjunctival 5-FU injections. * PATIENTS AND METHODS: Forty-one eyes of 41 patients with advanced, medically uncontrolled glaucoma underwent trabeculectomy with intraoperative episcleral application of 5-FU (50 mg/ml for 5 minutes). A variable number of subconjunctival 5-FU injections were administered postoperatively at the discretion of the operating surgeon. * RESULTS: Six-, 12-, and 15-month life-table success rates (5 mm Hg ≤ intraocular pressure [IOP ≤ 21 mm Hg) were 100%, 97%, and 83%, respectively. Mean postoperative IOP was 12.1 ± 4.3 mm Hg. An average of 2.2 ± 1.6 (range 0 to 7) supplemental subconjunctival 5-FU injections were administered postoperatively. Corneal epithelial erosions developed in 7 (17%) of the eyes. Five of 7 patients who underwent subsequent surgical procedures maintained successful control of IOP at an average of 11.0 ± 4.8 (range 5 to 16) months after the secondary surgery. * CONCLUSION: Trabeculectomy with intraoperative 5-FU is effective in controlling IOP while possibly minimizing the need for frequent postoperative injections and the occurrence of corneal epitheliopathy. [Ophthalmic Surg Lasers 1998;29:552-561.]
- 1 July 1998
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 29 (7) , 552-561
Trabeculectomy With Intraoperative 5-Fluorouracil
* BACKGROUND AND OBJECTIVE: To investigate the outcome and complication rates of trabeculectomy following the combined use of intraoperative, topical 5-fluorouracil (5-FU) and low-dose, postoperative subconjunctival 5-FU injections. * PATIENTS AND METHODS: Forty-one eyes of 41 patients with advanced, medically uncontrolled glaucoma underwent trabeculectomy with intraoperative episcleral application of 5-FU (50 mg/ml for 5 minutes). A variable number of subconjunctival 5-FU injections were administered postoperatively at the discretion of the operating surgeon. * RESULTS: Six-, 12-, and 15-month life-table success rates (5 mm Hg ≤ intraocular pressure [IOP ≤ 21 mm Hg) were 100%, 97%, and 83%, respectively. Mean postoperative IOP was 12.1 ± 4.3 mm Hg. An average of 2.2 ± 1.6 (range 0 to 7) supplemental subconjunctival 5-FU injections were administered postoperatively. Corneal epithelial erosions developed in 7 (17%) of the eyes. Five of 7 patients who underwent subsequent surgical procedures maintained successful control of IOP at an average of 11.0 ± 4.8 (range 5 to 16) months after the secondary surgery. * CONCLUSION: Trabeculectomy with intraoperative 5-FU is effective in controlling IOP while possibly minimizing the need for frequent postoperative injections and the occurrence of corneal epitheliopathy. [Ophthalmic Surg Lasers 1998;29:552-561.]
- 1 October 1992
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 23 (10) , 702-707
Filtering Seton Implant for Glaucoma: Initial Animal Trial
A newly developed silicone filtering seton device was implanted in each of five eyes of four rhesus monkeys after they had undergone extensive argon-laser trabeculoplasty to raise their intraocular pressure (IOP). One animal (one implant eye) was killed at 6 weeks. The other three animals (four implant eyes) were observed for 17 to 24 months following implantation surgery. Mild to moderate postoperative inflammation subsided during the first postoperative week. The eyes remained quiet throughout the remainder of follow up. The postoperative IOPs varied between 18% and 70% of the IOPs at the time of implant surgery. In the three monkeys that had unilateral surgery, the IOP at the final follow-up measurement was equal to or lower than the IOP in the unoperated fellow eye. In the monkey that had bilateral surgery, both of the final IOPs were lower than the preoperative ones.
- 1 October 1992
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 23 (10) , 702-707
Filtering Seton Implant for Glaucoma: Initial Animal Trial
A newly developed silicone filtering seton device was implanted in each of five eyes of four rhesus monkeys after they had undergone extensive argon-laser trabeculoplasty to raise their intraocular pressure (IOP). One animal (one implant eye) was killed at 6 weeks. The other three animals (four implant eyes) were observed for 17 to 24 months following implantation surgery. Mild to moderate postoperative inflammation subsided during the first postoperative week. The eyes remained quiet throughout the remainder of follow up. The postoperative IOPs varied between 18% and 70% of the IOPs at the time of implant surgery. In the three monkeys that had unilateral surgery, the IOP at the final follow-up measurement was equal to or lower than the IOP in the unoperated fellow eye. In the monkey that had bilateral surgery, both of the final IOPs were lower than the preoperative ones.